MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0231337
Lysca Pharmaceuticals Private Limited
Lysca Pharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.08 Cr
▼ 48% YoY
Net loss · FY 2024
₹18.31 Lakh
Net margin -17%
EBITDA · FY 2024
-₹6.54 Lakh
EBITDA margin -6.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Lysca Pharmaceuticals Private Limited
Data last updated:
Lysca Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC339574. Its GSTIN is 27AAECL2047F1ZQ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bimal Naresh Patel and Jitendra Pandurang Suryavanshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No R – 890 2nd Floor MIDC Rabale Ttc Industrial Area Rabale, Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.08 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹18.31 Lakh (net margin -17%) and EBITDA of -₹6.54 Lakh (EBITDA margin -6.1%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years.
Lysca Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0231337).
Company details
CIN U24230MH2020PTC339574
Registration Number 339574
Incorporation Date 27 April 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0231337
Recognitions & Rankings of Lysca Pharmaceuticals
Contact details
Lysca Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No R – 890 2nd Floor MIDC Rabale Ttc Industrial Area Rabale, Navi Mumbai, Maharashtra, India – 400708
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lysca Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lysca Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lysca Pharmaceuticals is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Lysca Pharmaceuticals Private Limited, buy the company report.
Financials of Lysca Pharmaceuticals Private Limited
FY 2025 filings availableLysca Pharmaceuticals Private Limited reported revenue of ₹1.08 Cr (down 48% YoY) for FY 2024.
Revenue · FY 2024
₹1.08 Cr ▼ 48%
Net loss · FY 2024
₹18.31 Lakh margin -17%
EBITDA · FY 2024
-₹6.54 Lakh margin -6.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▲ 116%
EBITDA CAGR growth
1 year
▼ 133%
3 years · compounded
▲ 12%
Revenue fell 48% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 116%. EBITDA fell 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6.54 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹18.31 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6.1% | |||
| Net Profit Margin | -17% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Lysca Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lysca Pharmaceuticals Private Limited
Lysca Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bimal Naresh Patel | Director | 25 Jun 2020 | 6 Years 3 Months | Current |
| Jitendra Pandurang Suryavanshi Also directs: Niramay Pharmaceuticals Private Limited | Director | 24 Dec 2021 | 4 Years 9 Months | Current |
Auditor
Lysca Pharmaceuticals Private Limited is audited by SNH & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SNH & Associates | FY 2023 | 132819W |
Shareholding
The shareholding of Lysca Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lysca Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lysca Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lysca Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lysca Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 21, 2024.
Active EPFO establishments
1
GST
Lysca Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECL2047F1ZQ | Maharashtra | Active | 23 May 2020 |
To see the full GST registrations and return filing status of Lysca Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lysca Pharmaceuticals Private Limited has 7 board changes on record since 2020: 3 appointments and 4 cessations. The latest: Gopalkrishna Raghunath Shenoy ceased to be Director on 04 Jul 2022.
AGM
Lysca Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lysca Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Gopalkrishna Raghunath Shenoy ceased to be Director.
Ceased
Bimal Naresh Patel ceased to be Additional Director.
Ceased
Hitesh Jayantilal Vagadia ceased to be Additional Director.
Appointed
Jitendra Pandurang Suryavanshi was appointed as Director.
Appointed
Hitesh Jayantilal Vagadia was appointed as Director.
Appointed
Bimal Naresh Patel was appointed as Director.
Ceased
Nandini Gopalkrishna Shenoy ceased to be Director.
Incorporation
27 Apr 2020
Lysca Pharmaceuticals Private Limited was registered on 27 Apr 2020 with Roc Mumbai & aged 6 years 5 months as per MCA records.
Frequently asked questions
Lysca Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2020 (6+ years old) and is registered under CIN U24230MH2020PTC339574.
Lysca Pharmaceuticals has 2 current directors:
- Bimal Naresh Patel - Director
- Jitendra Pandurang Suryavanshi - Director
The latest financial statements of Lysca Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Lysca Pharmaceuticals is 27AAECL2047F1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lysca Pharmaceuticals is U24230MH2020PTC339574. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lysca Pharmaceuticals was incorporated on 27 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Gopalkrishna Raghunath Shenoy ceased to be Director on 04 Jul 2022. Bimal Naresh Patel ceased to be Additional Director on 24 Dec 2021. Hitesh Jayantilal Vagadia ceased to be Additional Director on 24 Dec 2021. Lysca Pharmaceuticals has 7 board changes on record in total.
Yes, Lysca Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0231337).
The registered office of Lysca Pharmaceuticals is at Plot No R – 890 2nd Floor MIDC Rabale Ttc Industrial Area Rabale, Navi Mumbai, Maharashtra, India – 400708.
Lysca Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.